Optimization of Insomnia Treatment in Primary Care
- Conditions
- Insomnia Disorder
- Interventions
- Drug: HypnoticsBehavioral: Online CBTBehavioral: Face-to-face CBT
- Registration Number
- NCT03633305
- Lead Sponsor
- Laval University
- Brief Summary
The primary objective of this pragmatic clinical trial is to evaluate the efficacy, feasibility, and adaptability of pharmacological and non-pharmacological treatments for insomnia disorder, delivered in primary care clinics. The second objective is to evaluate the efficacy of a sequential (stepped care) approach for persistent insomnia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- Aged 18 years or over
- Meeting criteria for insomnia disorder
- Registered patient at one of the primary care clinics participating in the study
- Fluent in French
- Computer and internet access
- Unstable or untreated psychiatric disorder
- Lifetime psychotic or bipolar disorder
- Current suicide risk
- Progressive or unstable medical disorder
- Untreated sleep disorder other than insomnia
- Use of medication altering sleep
- Irregular or atypical sleep-wake schedule
- Current or planned pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Treatment as usual Hypnotics Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online cognitive behavior therapy Online CBT Online CBT- Internet self-help program for insomnia with 6 cores Treatment as usual + Online CBT Hypnotics Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online CBT- Internet self-help program for insomnia with 6 cores Treatment as usual + Online CBT Online CBT Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks Online CBT- Internet self-help program for insomnia with 6 cores Medication Hypnotics Hypnotics - Medication used 1 to 7 nights/week for 6 to 8 weeks (arms 1, 3, 4) In-person cognitive behavior therapy Face-to-face CBT Face-to-face CBT- Face-to-face therapy with 3 to 4 individual sessions in a period of 6 to 8 weeks.
- Primary Outcome Measures
Name Time Method Remission of insomnia Post-2 (after 6-week treatment phase 2) Insomnia Severity Index score (average of two consecutive weeks \< 8, with none \> 10)
- Secondary Outcome Measures
Name Time Method Total sleep time from sleep diary Post-2 (after 6-week treatment phase 2) Mean total sleep time per night in minutes from sleep diary
Sleep efficiency from actigraphy Post-2 (after 6-week treatment phase 2) Mean sleep efficiency in percentage (total sleep time divided by time spent in bed, multiplied by 100) from actigraphy
Depression Post-2 (after 6-week treatment phase 2) Patient Health Questionnaire (PHQ-9)
Anxiety Post-2 (after 6-week treatment phase 2) Generalized Anxiety Disorder 7-item (GAD-7)
Disability Post-2 (after 6-week treatment phase 2) Work and Social Adjustment Scale (5-item scale scale assessing functional impact of insomnia; total score ranging from 0 to 40, higher scores indicating greater disability)
Medication use Post-2 (after 6-week treatment phase 2) Frequency of use (number of nights/week)
Total wake time from sleep diary Post-2 (after 6-week treatment phase 2) Mean total wake time (combining sleep onset latency, wake after sleep onset, and duration of early morning awakening) in minutes from sleep diary
Sleep efficiency from sleep diary Post-2 (after 6-week treatment phase 2) Mean sleep efficiency in percentage (total sleep time divided by time spent in bed, multiplied by 100) from sleep diary
Total sleep time from actigraphy Post-2 (after 6-week treatment phase 2) Mean total sleep time per night in minutes from actigraphy
Total wake time from actigraphy Post-2 (after 6-week treatment phase 2) Mean total wake time (combining sleep onset latency, wake after sleep onset, and duration of early morning awakening) in minutes from actigraphy
Fatigue Post-2 (after 6-week treatment phase 2) Flinders Fatigue Scale (7-item self-report scale measuring fatigue over the past two weeks; total score ranges from 0 to 31, higher scores indicating greater fatigue)
Trial Locations
- Locations (1)
Laval University
🇨🇦Quebec City, Quebec, Canada